MaxCyte, Inc. (MXCT) Financials

MXCT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 194.5 million 26.6 million
Dec. 31, 2025 202.5 million 31.0 million
Sept. 30, 2025 213.5 million 33.2 million
June 30, 2025 219.8 million 29.0 million

MXCT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -8.4 million ?
Dec. 31, 2025 -2.9 million 706000
Sept. 30, 2025 -7.8 million 2.0 million
June 30, 2025 -10.4 million 3.5 million

MXCT Net Income

No data available :(

MXCT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 14.6 million 16.1 million -
Dec. 31, 2025 103.0 million - 16.5 million
Sept. 30, 2025 105.7 million - 18.2 million
June 30, 2025 126.6 million - 18.5 million

MXCT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 106.9 million
Dec. 31, 2025 106.4 million
Sept. 30, 2025 106.3 million
June 30, 2025 106.4 million

MXCT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 222000 3.9 million 9.4 million 3.4 million
Dec. 31, 2025 231000 3.3 million 9.0 million 3.5 million
Sept. 30, 2025 300000 5.3 million 9.9 million 3.9 million
June 30, 2025 584000 6.3 million 13.9 million 5.8 million

MXCT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 9.7 million 2.6 million
Dec. 31, 2025 7.3 million 1.6 million
Sept. 30, 2025 6.8 million 516000
June 30, 2025 8.5 million 1.5 million

MXCT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MXCT

Price: $1.08

52 week price:
0.64
2.37

Earnings Per Share: -0.36 USD

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 508900

Market Capitalization: 130.2 million

Links: